TAYLOR KALTENBACH: Open Payments
NPI 1699546317 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,213 in 168 payments from 28 companies in 2025. Trend: 2023 $0 · 2024 $2,514 · 2025 $2,213
Food & beverage: $2,198Education: $16
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 47 | $354 |
| Novo Nordisk Inc | 12 | $216 |
| Madrigal Pharmaceuticals | 23 | $189 |
| Tandem Diabetes Care, Inc. | 11 | $164 |
| Corcept Therapeutics | 13 | $156 |
| Amneal Pharmaceuticals LLC | 8 | $142 |
| Xeris Pharmaceuticals, Inc. | 8 | $135 |
| Lilly USA, LLC | 9 | $127 |
| Antares Pharma, Inc. | 6 | $106 |
| Sequel Med Tech, LLC | 1 | $73 |
Products named: Dexcom G6 Transmitter, REZDIFFRA, t:slim X2 Insulin Pump with Control-IQ, Korlym, UNITHROID, RECORLEV, XYOSTED, JARDIANCE.
Industry payments across PA — which companies pay providers there.
